Spero Therapeutics Balance Sheet
Spero Therapeutics's total assets for Q4 2025 were $68.92M, an increase of 27.23% from the previous quarter. SPRO total liabilities were $9.90M for the fiscal quarter, a -64.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.